1 Jun 2026 09:00

Reassessing Tramadol Use in Chronic Pain

Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTEmma Murter, PharmD, MPHClinical Pharmacist, Intermountain Health

GET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. 

Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates- Practical continuing education across patient care topics 

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. 

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

 CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

 CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Summarize the current evidence on tramadol’s efficacy and safety profile in chronic pain based on placebo-controlled randomized trials.2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.

Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-223-H01-PInitial release date: 6/1/2026Expiration date: 6/1/2027Additional CPE details can be found here.

Follow CEimpact on Social Media:LinkedInInstagram


Отзывы


Podcastly – лучшая платформа для любителей подкастов. Более 10 миллионов аудио контента доступных на Android/iOS/Web/Desktop и Telegram.